Physician profile
Kevin M Wong
NPI 1437177193
$18,491.91
in general payments reported to CMS, 2019-2025
52 companies · $4,727 in 2025
The $4,727 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2020: $1,514 · 2021: $2,126 · 2022: $2,498 · 2023: $2,744 · 2024: $3,787 · 2025: $4,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,487 · Consulting Fee: $1,750 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,487.32 |
| Consulting Fee | $1,750.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,003.77 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $2,361.91 | 2019-2025 | Krystexxa, Otezla, Repatha |
| Novo Nordisk INC | $2,175.30 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $1,678.86 | 2019-2024 | Xarelto, Spravato |
| Abbvie INC. | $1,567.32 | 2021-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $926.75 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $688.08 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $675.16 | 2019-2025 | |
| Lilly USA, LLC | $649.46 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $534.81 | 2021-2025 | |
| Exact Sciences Corporation | $490.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $341.68 | 2022 | |
| Glaxosmithkline, LLC. | $337.10 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $318.70 | 2019-2024 | Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $217.40 | 2021-2025 | Xifaxan, Trulance |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $216.56 | 2019-2024 | Sublocade |
| Edwards Lifesciences Corporation | $197.33 | 2024 | |
| Medtronic, INC. | $183.93 | 2024 | Intellis Adaptivestim |
| Esperion Therapeutics, INC. | $154.11 | 2021-2022 | |
| Axsome Therapeutics, INC. | $134.82 | 2024-2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.23 | 2022 | |
| Nestle Healthcare Nutrition INC. | $122.89 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $112.85 | 2023-2025 | Zilretta, Iovera |
| Bioventus LLC | $108.94 | 2020-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Orexo US, INC. | $88.56 | 2019-2024 | Zubsolv |
| Lundbeck LLC | $85.40 | 2024-2025 | Rexulti |
| Abbott Laboratories | $84.64 | 2023-2025 | Freestyle Libre 3, Supera, Freestyle Libre 2 |
| Otsuka America Pharmaceutical, INC. | $84.22 | 2023-2025 | Rexulti, Nuedexta |
| Aimmune Therapeutics, INC. | $78.73 | 2025 | Zenpep, Vowst |
| Inspire Medical Systems, INC. | $66.23 | 2025 | Inspire |
| Collegium Pharmaceutical, INC. | $58.53 | 2019-2025 | Belbuca |
| Ibsa Pharma INC. | $56.32 | 2024 | Tirosint, Licart |
| Grt US Holding, INC. | $52.92 | 2021 | |
| Electronic Waveform Lab, INC. | $49.76 | 2023 | |
| Astellas Pharma US INC | $48.81 | 2022-2024 | Veozah |
| Teva Pharmaceuticals USA, INC. | $44.25 | 2019 | |
| Millicent US INC | $40.38 | 2025 | Femlyv, Intrarosa |
| Boston Scientific Corporation | $34.55 | 2023 | Watchman Access System |
| Kowa Pharmaceuticals America, INC. | $30.30 | 2025 | Zoryve |
| Insulet Corporation | $28.46 | 2024 | Omnipod |
| Seqirus USA INC | $26.37 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.79 | 2025 | Caplyta |
| Eisai INC. | $21.88 | 2023 | |
| Shield Therapeutics INC | $20.86 | 2023 | Accrufer |
| Philips North America LLC | $20.00 | 2022 | |
| Pacira Therapeutics, INC. | $18.96 | 2021 | |
| Sonex Health, INC. | $18.82 | 2024 | Sx-One Microknife |
| Depuy Synthes Sales INC. | $18.60 | 2025 | Monovisc |
| Biohaven Pharmaceuticals, INC. | $18.42 | 2021 | |
| Acadia Pharmaceuticals INC | $18.20 | 2024 | Nuplazid |
| Orthofix Medical, INC. | $15.98 | 2023 | Physio-Stim |
| Ultragenyx Pharmaceutical INC. | $12.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.